Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for hyperactivity and attention difficulties in children and individuals. In Canada, its access is managed by Health Canada. This https://apo-lisdexamfetamine-pri159527.popup-blog.com/41758682/vyvanse-in-canada-a-detailed-guide